PRINCETON, N.J., Feb. 07, 2019 (GLOBE NEWSWIRE) — Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, announced today that its Chairman and Chief Executive Officer, Al Altomari will present at the 2019 BIO CEO & Investor conference on Tuesday February 12, 2019 at 10:30 AM Eastern Time.  The conference will be held at the New York Marriott Marquis.

To access the live and archived webcasts of the presentation, visit the Investor Relations section of the Agile Therapeutics website at www.agiletherapeutics.com.  The webcast will be archived on the Agile Therapeutics website for 60 days following the event.

About Agile Therapeutics, Inc.
Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women.  Our product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method.  Our lead product candidate, Twirla^®, (ethinyl estradiol and levonorgestrel transdermal system), also known as AG200-15, is an investigational low-dose, non-daily prescription contraceptive. Twirla is based on our proprietary transdermal patch technology, called Skinfusion^®, which is designed to allow drug delivery through the skin. For more information, please visit the company website at www.agiletherapeutics.com. The Company may occasionally disseminate material, nonpublic information on the Company’s website. 

Contact:  Investor Relations — 609-683-1880